community download

The Netherlands: In the mi(d)st of change

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

 

 

 

Martin Van der Graaf, Secretary, Medicinal Product Reimbursement Committee, CVZ explores:

  • Organisational change in CVZ
  • End of an era: Policy rules and outcomes research
  • First results and experiences with CED
  • Preliminary criteria for prioritizing inpatient drugs
  • Are orphan drugs exceptional?
  • Conditional reimbursement & financing